NeuroPace Q3 2026 revenue miss and full‑year guidance cut
NeuroPace reported third‑quarter 2026 revenue of $23.1 million, well below analyst forecasts of roughly $27 million. The company cut its full‑year 2026 revenue outlook to $91‑92 million from the prior $99.5‑101.5 million range and warned that sales‑force disruptions and account‑specific issues weighed on results. CEO Joel Becker said the shortfall was driven by transient operational challenges and that the firm is taking actions to improve execution. The earnings release triggered a sharp sell‑off, with the stock falling more than 35% after hours.
Why it matters
KeyBanc lowered its price target to $14 from $18 and Leerink cut its target to $7, reflecting the reduced growth outlook (KeyBanc note). The guidance cut and earnings miss have driven the stock to trade well below its prior levels, increasing downside risk for investors.
Key facts
- 1Q3 2026 revenue was $23.1 million tradingview.com
- 2Revenue missed analyst expectations of $27.1 million finance.yahoo.com
- 3Full‑year 2026 revenue guidance was revised to $91 million‑$92 million seekingalpha.com
- 4Cash and cash equivalents at quarter‑end were $49.5 million, down from $51.9 million tradingview.com
- 5The stock fell about 35% in after‑hours trading following the release investing.com
- 6CEO Joel Becker attributed the miss to sales‑force restructuring and account‑specific operational issues finance.yahoo.com
Summary written by AlphAI AI Desk from 11 of 11 sources. Not investment advice. Figures are as stated by the linked sources.